A Win-Win Multiple Sclerosis Deal? - Biogen Idec Inc. (BIIB), Elan Corporation, plc (ELN)
Biogen Idec Inc. (NASDAQ:BIIB) is buying the full rights to multiple sclerosis drug Tysabri from Elan Corporation, plc (ADR) (NYSE:ELN) for $3.25 billion.
Novartis A G (NVS)
Market is closed
News
- First
- << Previous
- 281 - 283
Buy, Sell, or Hold: Astex Pharmaceuticals, Inc. (ASTX)
When considering any stock for your portfolio, don't be swayed by just the positives. Examine its pros and cons and decide whether its possible upside outweighs its risks.
3 Things to Watch at Momenta Pharmaceuticals, Inc. (MNTA)
Despite its name, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months.
- First
- << Previous
- 281 - 283
Billionaire Hedge Funds
